Why more red light isn't better
This describes published research on photobiomodulation, not a treatment plan. Follow your device's instructions, protect your eyes, and consult a clinician for medical concerns.
Most dosing intuitions assume "more is better, or at least not worse." Red light therapy breaks that assumption. The relationship between dose and effect is biphasic: it rises to a peak and then falls off — so pushing the dose past the helpful window can do less than the right dose, not more.
The three zones
| Dose | What the research describes |
|---|---|
| Too low | Below threshold — little or no measurable effect |
| Optimal window | The dose range where benefits are observed |
| Too high | Effect drops off and can become inhibitory |
This pattern — an old idea sometimes called the Arndt–Schulz curve — was reviewed for low-level light therapy by Huang, Chen, Carroll, and Hamblin, whose work made the biphasic response a central caution in the field. It's why "stand in front of the panel twice as long" is not a safe assumption.
What it means for your sessions
- Aim for a target dose, not maximum time. Compute J/cm² and stop there rather than treating longer as strictly better.
- Account for stacking. Closer distance, higher-power panels, and longer time all add to the same dose — combine them and you can overshoot the window without realizing it.
- Consistency over intensity. A sensible dose done regularly is more in keeping with the research than occasional very long sessions.
The optimal window isn't one universal number. It depends on wavelength, tissue, and goal, and the literature reports ranges rather than a single dose. Treat published figures as guardrails, not guarantees, and follow your device's guidance.
Lumen keeps your dose inside the window
Set a target and Lumen computes session time for your device and distance — flagging when a longer session would push you past sensible dose ranges, using biphasic-window guardrails drawn from the Hamblin research. Free to download.
Sources
- Huang, Chen, Carroll & Hamblin, "Biphasic dose response in low level light therapy" (PMID 22461763)
- Reviews of photobiomodulation dose-response (optimal-window ranges)
Photobiomodulation dosing is an active research area; figures are guardrails, not prescriptions.